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Synthetic procedures
Synthesis of MnMEIO-mPEG NPs
MnMEIO NPs were prepared according to the literature report [S1] using iron acetylacetonate and manganese chloride as the iron and manganese precursor respectively, oleic acid and oleylamine as the ligands, and benzyl ether as the solvent. MnMEIO-mPEG NPs were obtained by ligand exchange reaction. [S2] In the typical ligand exchange reaction, synthesized MnMEIO NPs (56 mg, 0.24 mmol) were dispersed in toluene (20 mL) in a round-bottom flask, followed by the addition of silane-NH 2 -mPEG (600 mg, 0.24 mmol). The resulting solution was sonicated for 6 hrs at 50 °C. The silane-NH 2 -mPEG-coated NPs were precipitated by addition of hexane and isolated via centrifugation (1,000 × g). After decanting the supernatant, the precipitate was re-dispersed in hexane for three times. Then, the particle was dispersed in deionized water and purified by dialysis against deionized water (M.W. = 50 kDa). Selected IR bands (ν in cm 
Synthesis of CyTE777
The CyTE777 dye was prepared according to the literature report. 
Production of recombinant bispecific antibody
The recombinant tetravalent bispecific antibody (Bis) was obtained by stable transfection of the expression constructs in CHO-RD cells and reseeded in semi-solid medium for second run of stable clone selection. After 10~14 days of culture, colonies were imaged and picked using an automated robotic colony picker. A stable clone with high bispecific antibody expression was cultured in a shaker flask (5 × 10 5 cells/mL) after two runs of selection. The bispecific antibody was purified using protein A affinity chromatography.
Determination of bispecific antibodies binding affinity
The binding affinity of bispecific Ab for EGFR and HER2/neu was measured in enzyme-linked immunosorbent assay (ELISA) experiments. Soluble EGFRv3-ECD-hFc and Her2-ECD-hFc were coating on ELISA plates at 10 µg/mL and binding of bispecific antibodies was detected via a horseradish peroxidase-conjugated rabbit anti-c-myc antibody. The binding affinity (KD value) of bispecific antibodies was ~10 and ~3 nM for soluble EGFRv3-ECD-hFc and Her2-ECD-hFc, respectively, assayed in three times independent experiments. Data were analyzed through GraphPad Prism software. were dissolved in DMSO (5 mL) and allowed to react for 20 min at room temperature.
Subsequently, MnMEIO-mPEG NPs (100 mg) were dispersed in deionized water (5 mL), added into the mixture, and shaken vigorously for overnight at 4 °C in the dark. Excess EDC was removed by centrifugation (1,000 × g) and dialyzed (M.W. = 12 kDa~14 kDa) against deionized water to yield MnMEIO-CyTE777-mPEG NPs. After that, the -COOH moiety of antibody (20 µL of bispecific (Bis) (1 mg/mL)) was activated by EDC/NHS. MnMEIO-CyTE777-mPEG NPs (100 mg) were dispersed in PBS buffer (5 mL), mixed with activated antibody solution, and reacted for overnight at 4 °C in the dark. After reaction, the crude mixture was purified by Iron contents of nanoparticles were estimated by dissolving the dried samples in 70% nitric acid (50 μL), and subjecting to ICP-MS analysis.
[S5]
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Synthesis of MnMEIO-FITC-(Bis)-mPEG NPs and control NPs (MnMEIO-FITC-mPEG,
MnMEIO-FITC-(Her)-mPEG, MnMEIO-FITC-(Erb)-mPEG, and
MnMEIO-FITC-(Erb+Her)-mPEG NPs)
MnMEIO 
Blocking study
All tumor cells (SKBR-3, A431, Colo-205, MCF-7, MDA-MB-231 cells) were were plated in 96-well plate at a density of 1 × 10 4 cells/well for 24 hrs. These tumor cells were pretreated with with excess Herceptin, Erbitux, and both antibodies, respectively, for 1 hr at 37 °C, following by incubated with MnMEIO-CyTE777-(Bis)-mPEG NPs for 1 hr. After incubation, the supernatants were removed and cells washed three times with PBS. The optical imaging was then acquired using an IVIS spectrum system. The emission at 820 nm was measured with an optimal excitation wavelength of 745 nm (1 sec, F-stop = 2 and small binning). Data is represented as mean ± SD (n = 4).
S7
Supporting data
Fig. S1
The binding affinity study of bispecific antibody for EGFRv3-ECD-hFc and Her2-ECD-hFc.
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Fig . S2 EDS spectra of as-synthesized MnMEIO. In these experiments NPs (10 µg/mL) were incubated with cells for 1 hr at 4 °C. Cell-associated fluorescent intensities were analyzed with a FACScan flow cytometer. MnMEIO-CyTE777-(Erb+Her)-mPEG NPs) (10 µg/mL) for 1 hr at 37 °C. 
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